Align Technology Inc (ALGN)
Sector: Healthcare
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country: United States
Exchange: NASDAQ
Market cap: $10.35B
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Latest financial period: June 30, 2026
Filed with the SEC: August 5, 2026
Estimated earnings date: November 4, 2026
Profit #701 of 1480 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 53.7% | 55.9% | 55.6% | 54.4% |
Growth #1124 of 1480 companies
Payout #186 of 1480 companies
Safety #229 of 1480 companies
Price #531 of 1480 companies
